1. SAT0219 Efficacy and safety of atacicept in patients with high disease activity in a 24-week, randomized, placebo-controlled, phase iib study (ADDRESS II). (15th June 2017) Authors: Merrill, JT; Wallace, DJ; Kao, A; Mateo, C Vazquez; Fraser, PA; Chang, P; Isenberg, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0236 Safety and disease activity changes in an extension of a phase IIB study of atacicept in patients with SLE (address II). (15th June 2017) Authors: Wallace, DJ; Isenberg, D; Wax, S; Kao, A; Chang, P; Fraser, PA; Merrill, JT Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗